AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Legal Implications of Brand Drugs and Compounding Pharmacies
The chapter explores the legal aspects surrounding brand drugs Ozambic and Wake Ovi, both containing semaglutide, and discusses the involvement of compounding pharmacies in drug development. It delves into the complexities of patents, trademarks, and FDA regulations regarding the use of semaglutide amidst drug shortages. The conversation raises questions about the timing of compounding pharmacies' participation and the legality of using them for private practices before patent protection expires.